Buprenorphine , a partial agonist available in formulations such as Suboxone (combined with naloxone), Sublocade, and Brixadi, presents a lower risk of overdose and has become a mainstay of outpatient care
Phase 3 trials evaluating oral semaglutide in early-stage symptomatic Alzheimers disease did not meet their primary endpoints, tempering the earlier hypothesis that GLP-1s might offer direct neuroprotective benefits
Healthcare professionals should refer to the latest clinical trial data and regulatory updates when considering managing weight or other therapeutic purposes
, GHKCuliposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis, Wiley, Apr
Existing safety summaries are confined to regulatory labels, narrative reviews, and individual pharmacovigilance reports, whereas gastrointestinal adverse effects dominate the published safety discourse
Employers can analyze claims data and possibly health risk assessment data to estimate the prevalence of obesity, which has historically been grossly undercounted